Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

How to identify subjects with poly-vascular disease?

Vlachopoulos C, Terentes-Printzios D, Stefanadis C.

Curr Vasc Pharmacol. 2012 Nov;10(6):728-30. Review.

PMID:
23259567
2.

Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD.

Mourad JJ, Cacoub P, Collet JP, Becker F, Pinel JF, Huet D, Sevestre-Pietri MA, Priollet P; ELLIPSE scientific committee and study investigators.

J Vasc Surg. 2009 Sep;50(3):572-80. doi: 10.1016/j.jvs.2009.04.055. Epub 2009 Jun 27.

3.

Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry.

Suárez C, Zeymer U, Limbourg T, Baumgartner I, Cacoub P, Poldermans D, Röther J, Bhatt DL, Steg PG; REACH Registry Investigators.

Vasc Med. 2010 Aug;15(4):259-65. doi: 10.1177/1358863X10373299.

PMID:
20724374
4.

Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease.

Munakata M, Sakuraba J, Tayama J, Furuta T, Yusa A, Nunokawa T, Yoshinaga K, Toyota T.

Hypertens Res. 2005 Jan;28(1):9-14.

PMID:
15969249
5.

The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.

Xu Y, Wu Y, Li J, Ma W, Guo X, Luo Y, Hu D.

Hypertens Res. 2008 Jun;31(6):1079-85. doi: 10.1291/hypres.31.1079.

PMID:
18716354
6.

Management of patients with poly-vascular disease: priorities for revascularization procedures.

De Carlo M, Misuraca L.

Curr Vasc Pharmacol. 2012 Nov;10(6):731-3. Review.

PMID:
23259568
7.

Identification and management of polyvascular disease in patients with noncardioembolic ischaemic stroke.

Carolei A, Chamorro A, Laloux P, Leys D, Röther J, Sander D, Stansby G, Weimar C.

Int J Stroke. 2008 Nov;3(4):237-48. doi: 10.1111/j.1747-4949.2008.00220.x. Review.

PMID:
18811739
8.

Vascular stiffness: its measurement and significance for epidemiologic and outcome studies.

DeLoach SS, Townsend RR.

Clin J Am Soc Nephrol. 2008 Jan;3(1):184-92. doi: 10.2215/CJN.03340807. Review.

9.

Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.

De Backer J.

Verh K Acad Geneeskd Belg. 2009;71(6):335-71. Review.

PMID:
20232788
10.

An evidence-based score to detect prevalent peripheral artery disease (PAD).

Duval S, Massaro JM, Jaff MR, Boden WE, Alberts MJ, Califf RM, Eagle KA, D'Agostino RB Sr, Pedley A, Fonarow GC, Murabito JM, Steg PG, Bhatt DL, Hirsch AT; REACH Registry Investigators.

Vasc Med. 2012 Oct;17(5):342-51. doi: 10.1177/1358863X12445102. Epub 2012 Jun 17.

PMID:
22711750
11.

Diagnosis of vascular diseases. Ultrasound investigations--guidelines.

Antignani PL, Benedetti-Valentini F, Aluigi L, Baroncelli TA, Camporese G, Failla G, Martinelli O, Palasciano GC, Pulli R, Rispoli P, Amato A, Amitrano M, Dorigo W, Gossetti B, Irace L, Laurito A, Magnoni F, Minucci S, Pedrini L, Righi D, Verlato F; Italian Society for Vascular Investigation.

Int Angiol. 2012 Oct;31(5 Suppl 1):1-77. Review. No abstract available.

PMID:
23470846
12.

Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.

Uchiyama S, Goto S, Matsumoto M, Nagai R, Origasa H, Yamazaki T, Shigematsu H, Shimada K, Yamada N, Bhatt DL, Steg PG, Ikeda Y; REduction of Atherothrombosis for Continued Health Registry Investigators.

J Neurol Sci. 2009 Dec 15;287(1-2):45-51. doi: 10.1016/j.jns.2009.09.011. Epub 2009 Oct 7.

PMID:
19815240
13.

Limitation of brachial-ankle pulse wave velocity in assessing the risk of stroke: importance of instantaneous blood pressure.

Choi JC, Lee JS, Kang SY, Kang JH, Bae JM, Lee DH.

Cerebrovasc Dis. 2009;27(5):417-25. doi: 10.1159/000209236. Epub 2009 Mar 19.

PMID:
19295204
14.

From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.

Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force.

Am J Cardiol. 2006 Jul 17;98(2A):2H-15H. Epub 2006 Jun 12. Review.

PMID:
16843744
15.

Pulse wave velocity and the non-invasive methods used to assess it: Complior, SphygmoCor, Arteriograph and Vicorder.

Davies JM, Bailey MA, Griffin KJ, Scott DJ.

Vascular. 2012 Dec;20(6):342-9. doi: 10.1258/vasc.2011.ra0054. Epub 2012 Sep 7. Review.

PMID:
22962046
16.

Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.

Yakubov S.

Curr Med Res Opin. 2009 Nov;25(11):2631-41. doi: 10.1185/03007990903223895. Review.

PMID:
19769467
17.

Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease.

Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ.

J Am Coll Cardiol. 2004 Jan 21;43(2):179-84.

18.

A prospective comparison of bilateral photoplethysmography versus the ankle-brachial pressure index for detecting and quantifying lower limb peripheral arterial disease.

Allen J, Overbeck K, Nath AF, Murray A, Stansby G.

J Vasc Surg. 2008 Apr;47(4):794-802. doi: 10.1016/j.jvs.2007.11.057.

19.

Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction.

Kim SW, Paick J, Park DW, Chae I, Oh B.

Urology. 2001 Sep;58(3):441-5.

PMID:
11549496
20.

Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity.

Horinaka S, Yabe A, Yagi H, Ishimura K, Hara H, Iemua T, Matsuoka H.

Angiology. 2009 Aug-Sep;60(4):468-76. doi: 10.1177/0003319708325443. Epub 2008 Nov 17.

PMID:
19015165

Supplemental Content

Support Center